Dear Alumni,
It is our great pleasure to announce that this year�s PUAASC annual convention
will be held on Saturday May 18, 2002 in the China Press Culture Center,
Alhambra. For the first time in history, this alumni gathering will be
co-hosted by the Peking University Alumni Association (PUAASC) and Beijing
Medical University Alumni Association (BMUAA). Let's make new friends and have
fun!
We are proud to announce that two world-class biotech scholars Dr. Chien Shu
and Dr. Fu-Kuen Lin (see bios at the end of this message) will deliver keynote
speeches at the alumni gathering. Dr. Chien Shu entered Peking University
Medical School in 1947 and therefore he is an alumnus of both Peking University
and Beijing Medical University (now the Peking University Medical School).
A rich variety of activities including social time, ballroom dance, and career-
oriented discussions have been prepared for this great event. There will be
lots of fun and excitement in the gathering. We sincerely invite all alumni and
their families to attend. Let the great tradition of the two universities merge
together in Southern California!
Below is the detailed program:
Location:
Room 101
The China Press
2121 W. Mission Rd.
Alhambra, CA 91803
Date: May 18, 2002
Part I: Gathering and Convention
2:30 Registration and Social
3:00 Convention begins: Introduce alumni and speakers
3:15 Congratulatory letters from Peking University and Peking University
Medical School
3:20 Representatives from PUAASC and BMUAA Speak
3:40 Keynote Speech by Dr. Fu-Kuen Lin, Former Director of Department of
Biomedical Sciences, Amgen, Inc. and Recipient of the US National
Medal of Technology
Title: Commercialization of Biotech Research
4:20 Keynote Speech by Dr. Shu Chien, Chairman of UCSD Department of
Bioengineering, Member of US National Academy of Sciences and US
National Academy of Engineering, and Recipient of the "University
Professor" by the University of California
Title: Medical School in Peking University: History and Future
5:00 Gathering Concludes
Part II: Social and Food
5:00-6:00 Food and drinks will be served
Part III: Career-Oriented Discussions
6:00-7:00 Three Parallel Discussions:
with Dr. Shu, with Dr. Lin, and with China Science and Technology
Ministry Delegation (to be confirmed)
Part IV: Dance Party and Karaoke
6:30-9:30 Dance Party with Professional DJ
Admissiona:
1) Student/Senior:
Attend all four parts of the gathering: Free (also for significant others)
Attend dance party only: $5
2) Others:
Attend all four parts of the gathering: $10
Attend dance party only: $10
Because food will be served at the alumni gathering, reservation is required.
Please send your reservation to fzengsm@yahoo.com.
For further information, please contact the following alumni:
Feng Zeng
Chair, Convention Committee (fzengsm@yahoo.com, 310-393-0411 x 7320)
Sikun Lan
President, PUAASC (Sikun@yahoo.com, 310-625-1128)
Pu-Qing Yuan
President, BMUAA (pqyuan@ucla.edu, 310-478-3711 x 41877)
Best Regards,
PUAASC
4/26/2002
*****************************************************************************
Introductions to the Two Keynote Speakers:
1) Dr. Shu Chien
1931 Born in Hangzhou, Zhejiang, China
1947-1948 National Peking University Medical School
1953 National Taiwan University, M.D.
1957 Columbia University, Ph.D. in Physiology. Taught in Columbia University
for over twenty years before becoming the founding Department Chairman of the
Department of Bioengineering at University of California at San Diego till now
1976 Member, Academia Sinica, Taiwan
1981 Received First Fahraeus Medal (Clinical Hemorheology)
1983 Received Landis Award (Microcirculatory Society)
1985-1988 Special Creativity Grant Award (The National Foundation of Science)
1989-1998 Received NIH Merit Award (National Institute of Heart, Lung, and
Blood)
1990-1991 President, American Physiological Society
1990 and 1996 Melville Award (American Society Mechanical Engineers)
1991 Received Zweifach Award (Fifth World Congress for Microcirculation)
1992 Founding Fellow, American Institute of Medical and Biological Engineering
1992-1993 President, Federation of American Societies for Experimental Biology
1993 Received ALZA Award (Biomedical Engineering Society)
1994 Member, Institute of Medicine, National Academy of Sciences
1996 Received Joseph Mather Smith Prize for Distinguished Alumni Research,
Columbia University
1997 Member, National Academy of Engineering
1999 Received Ray Daggs Award (American Physiological Society)
2002 Awarded University Professor, University of California (Only about 20
people in the ten campuses of UC received this award.)
2002 Poiseuille Gold Medal (Biorheology). To be awarded at the 11th
International Congress of Biorheology in Antalya, Turkey in August 2002
2) Dr. Fu-Kuen Lin
1941 Born in Keelung, Taiwan
1964 National Taiwan University B.S.
1967 National Taiwan University M.S.
1971 University of Illinois at Urbana-Champaign, Ph.D. in Microbiology
1971-1981 Postdoctoral and research scientist at several academic institutions
1981 Joined Amgen, Inc., now the world largest and most successful biotech
company, as the group leader of the erythropoietin project
1989 FDA approved the recombinant human erythropoitin product Epoetin alfa. It
is marketed under the names of Epogen and Procrit in US, as Eprex in Europe. It
is currently being used to treat anemia of chronic renal failure patients on
kidney dialysis and non-dialysis, and anemia of AIDS patients and non-myeloid
cancer patients undergoing chemotherapy to replace blood transfusions.
Erythropoitin, discovered by Dr. Fu-Kuen Lin, has been the most successful
biotech product in history.
1989 Received Technology Corrid 100 Award
1990 Received Quality of Life Award
1994 Amgen, Inc. was awarded the National Medal of Technology by the President
of the United States of America based on the discovery and commercialization of
two major products, erythropoietin (Dr. Fu-Kuen Lin) and G-CSF (Dr. Larry
Souza). This award is the highest presidential tribute given in the United
States for extraordinary achievement in the commercial application of
technology and the equivalent of a Nobel Prize in the business industry.
1995 Received PhRMA Discovers Award
1998 Retired from Amgen, Inc. as the Director of Department of Biomedical
Sciences
2001 The combined worldwide sales of erythropoietin were 5.6 billion US
dollars. It is projected to reach to 9-10 billion US dollars in five years.